Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology

    Tumor markers in CNS germ cell tumors (GCTs) include human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP), which have significant diagnostic implications, as elevation of either one leads to clinical...

    Hirokazu Takami, Christopher S. Graffeo, Avital Perry in Brain Tumor Pathology (2023)

  2. No Access

    Article

    Hybrid tumors with perineurioma components: a systematic review of the literature and illustrative case

    Hybrid peripheral nerve sheath tumors (HPNST) are a newly recognized class of peripheral nerve sheath tumor, composed of at least two areas characteristic of perineurioma, schwannoma, or neurofibroma. The lite...

    Karina A. Lenartowicz, Dileep D. Monie, Kimberly K. Amrami in Acta Neurochirurgica (2023)

  3. No Access

    Article

    Histopathology and prognosis of germ cell tumors metastatic to brain: cohort study

    Germ cell tumors (GCTs) are uncommon neoplasms predominantly arising in midline tissues. The prognostic significance of histopathology in predicting metastatic GCT behavior is poorly understood.

    Hirokazu Takami, Christopher S. Graffeo, Avital Perry in Journal of Neuro-Oncology (2021)

  4. No Access

    Article

    Intracranial angiomatoid fibrous histiocytoma with rhabdoid features: a mimic of rhabdoid meningioma

    Angiomatoid fibrous histiocytoma (AFH) is an uncommon soft-tissue neoplasm that arises mostly in the extremities of young people and generally carries a good prognosis. Intracranial location is unusual and fre...

    M. Adelita Vizcaino, Caterina Giannini, Howard T. Chang in Brain Tumor Pathology (2021)

  5. No Access

    Chapter

    Adult Primary Central Nervous System Vasculitis

    Primary CNS vasculitis is an uncommon disorder of unknown cause that is restricted to brain and spinal cord. The median age of onset is 50 years. The neurological manifestations are diverse, but generally cons...

    Carlo Salvarani, Robert D. Brown Jr in Large and Medium Size Vessel and Single Or… (2021)

  6. No Access

    Article

    Plenty of calcification: imaging characterization of polymorphous low-grade neuroepithelial tumor of the young

    Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) is a recently described epileptogenic neoplasm. As the name implies, PLNTYs are indolent tumors most often encountered in the pediatric or youn...

    Derek R. Johnson, Caterina Giannini, Robert B. Jenkins, Dong Kun Kim in Neuroradiology (2019)

  7. Article

    Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

    The last author's first name was truncated in the initial online publication. The original article has been corrected.

    Kurt A. Jaeckle, S. K. Anderson, Erin L. Twohy, Jesse G. Dixon in Journal of Neuro-Oncology (2019)

  8. No Access

    Article

    Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

    To evaluate the pharmacokinetics and efficacy of imatinib in patients with recurrent oligodendroglial tumors.

    Kurt A. Jaeckle, S. K. Anderson, Erin L. Twohy, Jesse G. Dixon in Journal of Neuro-Oncology (2019)

  9. No Access

    Article

    Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-l-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas

    Treatment-related changes can be difficult to differentiate from progressive glioma using MRI with contrast (CE). The purpose of this study is to compare the sensitivity and specificity of 18F-DOPA-PET and MRI...

    Ryan S. Youland, Deanna H. Pafundi, Debra H. Brinkmann in Journal of Neuro-Oncology (2018)

  10. No Access

    Article

    Management of diffuse low-grade gliomas in adults — use of molecular diagnostics

  11. In the 2016 WHO classification of brain tumours, diffuse gliomas — including grade II gliomas — are defined by both morphological and molecular criteria

    ...
  12. Jan Buckner, Caterina Giannini, Jeanette Eckel-Passow in Nature Reviews Neurology (2017)

  13. No Access

    Article

    Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131

    We report on the long-term results of a phase II study of pre-irradiation temozolomide followed by concurrent temozolomide and radiotherapy (RT) in patients with newly diagnosed anaplastic oligodendroglioma (A...

    Michael A. Vogelbaum, Chen Hu, David M. Peereboom in Journal of Neuro-Oncology (2015)

  14. No Access

    Article

    The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma

    This study assesses the controversial role of temozolomide (TMZ) concurrent with adjuvant radiation (RT) in patients with anaplastic astrocytoma (AA). The impact of isocitrate dehydrogenase (IDH) status on the...

    Sani H. Kizilbash, Caterina Giannini, Jesse S. Voss in Journal of Neuro-Oncology (2014)

  15. No Access

    Article

    Interlaboratory comparison of IDH mutation detection

    Isocitrate dehydrogenase (IDH) mutational testing is becoming increasingly important. For this, robust and reliable assays are needed. We tested the variation of results between six laboratories of testing for...

    Martin J. van den Bent, C. Hartmann, Matthias Preusser in Journal of Neuro-Oncology (2013)

  16. No Access

    Article

    Gliomatosis cerebri: clinical characteristics, management, and outcomes

    Gliomatosis cerebri is a rare diffusely infiltrating primary neoplastic glial process of the brain. Our objective is to review clinical presentation, management, and outcome in a large single institution serie...

    Selby Chen, Shota Tanaka, Caterina Giannini, Jonathan Morris in Journal of Neuro-Oncology (2013)

  17. No Access

    Article

    The role of LAT1 in 18F-DOPA uptake in malignant gliomas

    Positron emission tomography (PET) imaging with the amino acid tracer 6-18F-fluoro-l-3,4-dihydroxy-phenylalanine (18F-DOPA) may provide better spatial and functional information in human gliomas than CT or MRI al...

    Ryan S. Youland, Gaspar J. Kitange, Timothy E. Peterson in Journal of Neuro-Oncology (2013)

  18. No Access

    Article

    Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance

    Temozolomide (TMZ) is the most effective chemotherapeutic agent for glioblastoma (GBM). Resistance to this methylating agent is linked to DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT). Howeve...

    Gaspar J. Kitange, Brett L. Carlson, Mark A. Schroeder in Journal of Neuro-Oncology (2010)

  19. No Access

    Article

    Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM

    Irinotecan has radiosensitizing effects and shows synergism with nitrosoureas. We performed a Phase II study of RT and irinotecan, followed by BCNU plus irinotecan in newly-diagnosed GBM. The MTD for patients ...

    Kurt A. Jaeckle, Karla V. Ballman, Caterina Giannini in Journal of Neuro-Oncology (2010)

  20. No Access

    Article

    Atypical Acute Hemorrhagic Leukoencephalitis (Hurst’s disease) Presenting with Focal Hemorrhagic Brainstem Lesion

    Acute hemorrhagic leukoencephalitis (AHL; Hurst’s disease) is a rare, severe, inflammatory CNS disease that is typically diffuse, multifocal and associated with petechial hemorrhage. The objective of this stud...

    Nuhad E. Abou Zeid, Joseph D. Burns, Eelco F. M. Wijdicks in Neurocritical Care (2010)

  21. No Access

    Article

    Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model

    CpG methylation within the O6-methylguanine-DNA-methyltransferase (MGMT) promoter is associated with enhanced survival of glioblastoma multiforme (GBM) patients treated with temozolomide (TMZ). Although MGMT prom...

    Gaspar J. Kitange, Brett L. Carlson, Ann C. Mladek in Journal of Neuro-Oncology (2009)

  22. No Access

    Article

    Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma

    Background Esthesioneuroblastoma (ENB) is a rare tumor arising from the olfactory epithelium in the upper nasal cavity. Prior reviews have found efficacy of chemotherapy for high grade tumors in the advanced sett...

    Alyx B. Porter, Dirk M. Bernold, Caterina Giannini in Journal of Neuro-Oncology (2008)

previous disabled Page of 2